Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer

Morimoto M, Toba H, Aoyama M, Nakagawa M, Takechi H, Yoshida T, Tangoku A

2020.12.23